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Haematoma Following Carotid Endarterectomy in the International
Carotid Stenting Study
Doig D., Turner E.L., Dobson J., Featherstone R.L., de Borst G.J.,
Brown M.M., Richards T., on behalf of the ICSS Investigators. Eur J
Vasc Endovasc Surg 2014;48:498-504.
Objective: Cranial nerve palsy (CNP) and neck haematoma are com-
plications of carotid endarterectomy (CEA). The effects of patient factors
and surgical technique were analysed on the risk, and impact on disability,
of CNP or haematoma in the surgical arm of the International Carotid
Stenting Study (ICSS), a randomized controlled clinical trial of stenting
versus CEA in patients with symptomatic carotid stenosis.
Materials and methods: A per-protocol analysis of early outcome in
patients receiving CEA in ICSS is reported. Haematoma was deﬁned by the
surgeon. CNP was conﬁrmed by an independent neurologist. Factors asso-
ciated with the risk of CNP and haematoma were investigated in a binomial
regression analysis.
Results: Of the patients undergoing CEA, 45/821 (5.5%) developed
CNP, one of which was disabling (modiﬁed Rankin score ¼ 3 at 1 month).
Twenty-eight (3.4%) developed severe haematoma. Twelve patients with
haematoma also had CNP, a signiﬁcant association (p < .01). Independent
risk factors modifying the risk of CNP were cardiac failure (risk ratio [RR]
2.66, 95% CI 1.11 to 6.40), female sex (RR 1.80, 95% CI 1.02 to 3.20), the
degree of contralateral carotid stenosis, and time from randomization to
treatment >14 days (RR 3.33, 95% CI 1.05 to 10.57). The risk of haema-
toma was increased in women, by the prescription of anticoagulant drugs
pre-procedure and in patients with atrial ﬁbrillation, and was decreased in
patients in whom a shunt was used and in those with a higher baseline
cholesterol level.
Conclusions: CNP remains relatively common after CEA, but is
rarely disabling. Women should be warned about an increased risk. Atten-
tion to haemostasis might reduce the incidence of CNP. ICSS is a registered
clinical trial: ISRCTN 25337470.
Treatment of Symptomatic Aberrant Subclavian Arteries
Jalaie H., Grommes J., Sailer A., Greiner A., Binnebösel M., Kalder J.,
Schurink G.W., Jacobs M.J. Eur J Vasc Endovasc Surg 2014;48:521-6.
Objective: The aim of this study is to present experience with 10 pa-
tients with symptomatic aberrant subclavian artery (ASA) and aneurysm of
ASA who underwent surgical treatment.
Methods: From 2008 to 2011 10 patients with symptomatic aberrant
subclavian artery (mean age 60 years [range 24e90 years]) were studied.
Symptoms were dysphagia (n ¼ 7), dyspnea (n ¼ 4), acute chest pain (n
¼ 1), respiratory distress syndrome (n ¼ 1), superior cava syndrome, and
shock (n ¼ 1). Six patients had aneurysm formation of the ASA (mean diam-
eter of 7.1 cm [range 3.0e12.4 cm]; rupture [n ¼ 1], dissection [n ¼ 1]).
All data were analyzed retrospectively.
Results: Treatment was performed as a hybrid procedure in eight pa-
tients. This included thoracic endoluminal graft exclusion with revasculari-
zation of the ASA, a pure endovascular procedure with two occluders in
one patient, and an open procedure in one patient with ligation of the aber-
rant artery through a thoracotomy. Three patients died during the early
postoperative period owing to pulmonary complications. All three suffered
from a symptomatic aneurysm, and two were treated as an emergency pro-
cedure. Median follow-up was 20 months (range 12e49 months).
Conclusion: A symptomatic ASA and its associated aneurysmal forma-
tion should be excluded after diagnosis. In most cases, a hybrid procedure con-
sisting of thoracic endografting and revascularization of the ASA is feasible.
Endograft Limb Occlusion in EVAR: Iliac Tortuosity Quantiﬁed by
Three Different Indices on the Basis of Preoperative CTA
Taudorf M., Jensen L.P., Vogt K.C., Grønvall J., Schroeder T.V., Lönn L.
Eur J Vasc Endovasc Surg 2014;48:527-33.
Objective: To assess the incidence and outcome of graft limb occlu-
sions after endovascular aortic repair (EVAR) of abdominal aortic aneurysm1396(AAA) in a high volume single centre. To quantify iliac artery tortuosity in
patients with AAA and correlate this with limb occlusion.
Design: Data were collected consecutively and prospectively, and
analyzed retrospectively.
Materials: Patients treated with Zenith bifurcated stent grafts from
January 2000 to December 2010 at a tertiary referral vascular unit were
analyzed. Routine regular ofﬁce follow-up with computed tomography
angiography (CTA) and, subsequently, duplex ultrasound imaging was per-
formed. Patients with limb occlusions were identiﬁed. For each index pa-
tient, two controls were obtained, one immediately preceding and one
following the index patient in the consecutive cohort of EVAR patients.
Methods: Demographics and CTA data on limb graft occlusions were
recorded and compared with a deﬁned control group. Three different
indices were used to describe the tortuosity of the iliac vessels based on pre-
operative CTA: pelvic artery index of tortuosity (PAI), common iliac artery
index of tortuosity (CAI), and a visual description of vessel tortuosity e the
double iliac sign (DIS). Demographic data and indices were correlated for
later occurring limb occlusion.
Results: 504 patients underwent EVAR and 18 patients experienced
graft limb occlusion during a median follow-up of 28 months (range
0e133). Primary graft patency was 97% at 1 year and 96% at 3 years. Logis-
tic regression showed that iliac artery tortuosity (DIS) (p ¼ .001) and body
mass index (p ¼ .007) had a signiﬁcant impact on graft patency.
Conclusion: A tortuous vessel on the preoperative CTA is associated
with an increased risk of limb occlusion after EVAR. Adjunctive stenting of
iliac segments deemed at risk is suggested, which is achieved without
compromise of the aneurysm repair.
Polytetraﬂuoroethylene Covered Stent Placement for Focal Occlusive
Disease of the Infrarenal Aorta
Grimme F.A.B., Reijnen M.M.P.J., Pﬁster K., Martens J.M., Kasprzak P.
Eur J Vasc Endovasc Surg 2014;48:545-50.
Background: Arterial insufﬁciency is rarely caused by isolated infrare-
nal aortic occlusive lesions. Endovascular treatment options include plain
balloon angioplasty and bare metal stent placement. In this study the feasi-
bility and efﬁcacy of polytetraﬂuoroethylene (PTFE) covered balloon
expandable stents were evaluated.
Material and methods: Consecutive patients from two centers were
prospectively collected in a database and retrospectively analyzed. Results
were evaluated by clinical examination, ankle-brachial indices (ABI), duplex
ultrasound, and plain abdominal radiography.
Results: Thirty-six consecutive patients were treated between
November 2008 and June 2013. Indication for treatment was Rutherford
3 (n ¼ 29), 4 (n ¼ 3), and 5 (n ¼ 4). Technical success was always achieved
and there were no distal embolizations or vessel wall ruptures. The median
follow-up was 22 months (range 0e60). All patients improved clinically and
the ABI increased signiﬁcantly from 0.73 6 0.18 to 1.01 6 0.14 (p < .01).
One patent covered stent was removed surgically because of infection. Pri-
mary patency rates were 100% at 1 and 2 years without stent fractures.
Conclusion: The use of PTFE covered stents for the treatment of iso-
lated infrarenal aortic occlusive disease is safe and very effective. Patency
rates are excellent and complications including distal embolization and
vessel wall rupture are extremely rare.
Low-dose Thrombolysis for Thromboembolic Lower Extremity Arterial
Occlusions is Effective Without Major Hemorrhagic Complications
Ebben H.P., Nederhoed J.H., Lely R.J., Meijerink M.R., van der
Meijs B.B., Wisselink W., Yeung K.K., Hoksbergen A.W.J. Eur J Vasc
Endovasc Surg 2014;48:551-8.
Objective: To evaluate the efﬁcacy and bleeding complications associ-
ated with a low-dose thrombolysis protocol for thromboembolic lower ex-
tremity arterial occlusions.
Design: A retrospective cohort study.
Materials and methods: A retrospective analysis was performed
using data from all consecutive patients who underwent catheter-directed,
